Back

dr. R.A.P. (Reinier) Raijmakers

dr. R.A.P. (Reinier) Raijmakers

Associate Professor - medical

Show full profile

Research Output (80)

Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients

Oostvogels Rimke, Jak Margot, Raymakers Reinier, Mous Rogier, Minnema Monique C. 1 Oct 2018, In: British Journal of Haematology. 183 , p. 60-67 8 p.

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients

Franssen Laurens E, Nijhof Inger S, Bjorklund Chad C, Chiu Hsiling, Doorn Ruud, van Velzen Jeroen, Emmelot Maarten, van Kessel Berris, Levin Mark-David, Bos Gerard M J, Broijl Annemiek, Klein Saskia K, Koene Harry R, Bloem Andries C, Beeker Aart, Faber Laura M, van der Spek Ellen, Raymakers Reinier, Sonneveld Pieter, Zweegman Sonja, Lokhorst Henk M, Thakurta Anjan, Qian Xiaozhong, Mutis Tuna, van de Donk Niels W C J 21 Sep 2018, In: Oncotarget. 9 , p. 34009-34021 13 p.

Feasibility and efficacy of addition of individualized dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

Kater Arnon P, van Oers Marinus H J, van Norden Yvette, van der Straten Lina, Driessen Julia, Posthuma Ward F M, Schipperus Martinus, Chamuleau Martine E D, Nijland Marcel, Doorduijn Jeanette K, Van Gelder Michel, Hoogendoorn Mels, De Croon Francien, Wittebol Shulamiet, Kerst J Martijn, Marijt Erik W A, Raymakers Reinier A P, Schaafsma Martijn R, Dobber Johan A, Kersting Sabina A, Levin Mark-David, 16 Aug 2018, In: Haematologica. 104 , p. 147-154 8 p.

Falsely decreased ferritin concentrations in two patients with haemophagocytic lymphohistiocytosis:A case report

Roozen Geert, Revet Ingrid, Raymakers Reinier, Kemperman Hans 9 Aug 2018, In: Annals of Clinical Biochemistry. 56 , p. 179-182 4 p.

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

Franssen Laurens E, Nijhof Inger S, Couto Suzana, Levin Mark-David, Bos Gerard M J, Broijl Annemiek, Klein Saskia K, Ren Yan, Wang Maria, Koene Harry R, Bloem Andries C, Beeker Aart, Faber Laura M, van der Spek Ellen, Raymakers Reinier, Leguit Roos J, Sonneveld Pieter, Zweegman Sonja, Lokhorst Henk, Mutis Tuna, Thakurta Anjan, Qian Xiaozhong, van de Donk Niels W C J Aug 2018, In: Haematologica. 103 , p. e368-e371

'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma

Rutten K H G, Raymakers R A P, Minnema M C Jul 2018, In: Netherlands Journal of Medicine. 76 , p. 249-250 2 p.

GMP-grade manufacturing of T cells engineered to express a defined γδTCR

Straetemans Trudy, Kierkels Guido J.J., Doorn Ruud, Jansen Koen, Heijhuurs Sabine, dos Santos Joao M., van Muyden Anna D.D., Vie Henri, Clemenceau Béatrice, Raymakers Reinier, de Witte Moniek, Sebestyén Zsolt, Kuball Jürgen 30 May 2018, In: Frontiers in Immunology [E]. 9

From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells

van Nieuwenhuijzen Niels, Spaan Ingrid, Raymakers Reinier, Peperzak Victor 15 May 2018, In: Cancer Research. 78 , p. 2449-2456 8 p.

Relative survival reaches a plateau in hairy cell leukemia:a population-based analysis in The Netherlands

Dinmohamed Avinash G, Posthuma Eduardus F M, Visser Otto, Kater Arnon P, Raymakers Reinier A P, Doorduijn Jeanette K 22 Mar 2018, In: Blood. 131 , p. 1380-1383 4 p.

Bortezomib before and after high-dose therapy in myeloma:long-term results from the phase III HOVON-65/GMMG-HD4 trial

Goldschmidt H, Lokhorst H M, Mai E K, van der Holt B, Blau I W, Zweegman S, Weisel K C, Vellenga E, Pfreundschuh M, Kersten M J, Scheid C, Croockewit S, Raymakers R, Hose D, Potamianou A, Jauch A, Hillengass J, Stevens-Kroef M, Raab M S, Broijl A, Lindemann H W, Bos G M J, Brossart P, van Marwijk Kooy M, Ypma P, Duehrsen U, Schaafsma R M, Bertsch U, Hielscher T, Jarari Le, Salwender H J, Sonneveld P Feb 2018, In: Leukemia. 32 , p. 383-390 8 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not